Skip to content
10-Q

Quarterly Report

Puramed Bioscience Inc.

0001354488-13-006509

← back to feed
Filed
Nov 19, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Nov 6, 2013 62.51M sh
Short Term Debt Q1 2014 · Sep 30, 2013 $481.49K
Short Term Debt Q1 2014 · Jun 30, 2013 $454.03K
Stockholders Equity Q1 2014 · Sep 30, 2013 −$3.4M
Stockholders Equity Q1 2014 · Jun 30, 2013 −$2.77M
Current Liabilities Q1 2014 · Sep 30, 2013 $3.74M
Current Liabilities Q1 2014 · Jun 30, 2013 $3.17M
Current Assets Q1 2014 · Sep 30, 2013 $265.02K
Current Assets Q1 2014 · Jun 30, 2013 $326.24K
Total Assets Q1 2014 · Sep 30, 2013 $410.79K
Total Assets Q1 2014 · Jun 30, 2013 $476.35K
Operating Cash Flow Q1 2014 · Sep 30, 2012 −$582.36K
Sga Expense Q1 2014 · Sep 30, 2012 $55.55K
Rd Expense Q1 2014 · Sep 30, 2012 $14.6K
Net Income Q1 2014 · Sep 30, 2012 −$780.66K
Operating Income Q1 2014 · Sep 30, 2012 −$561.09K
Gross Profit Q1 2014 · Sep 30, 2012 $14.49K
Cost Of Revenue Q1 2014 · Sep 30, 2012 $13.04K
Revenue Q1 2014 · Sep 30, 2012 $27.53K